Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
Research output: Contribution to journal › Journal article › Research › peer-review
Clinical differentiation between parkinsonian syndromes (PS) remains a challenge despite well-established clinical diagnostic criteria. Specific diagnostic biomarkers have yet to be identified, though in recent years, studies have been published on the aid of certain brain related proteins (BRP) in the diagnosing of PS. We investigated the levels of the light subunit of neurofilament triplet protein (NF-L), total tau and phosphorylated tau, amyloid-ß(1-42), and the soluble a- and ß-cleaved fragments of amyloid precursor proteins in a cohort of patients with various PS.
|Journal||Parkinsonism & Related Disorders|
|Number of pages||4|
|Publication status||Published - 2012|